APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Apremilast Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Apremilast Tablets Market Outlook and Growth Opportunities 2026

Report ID 173967020427 December 2025192 pages

Choose your research edition.

Industry ResearchApremilast Tablets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Apremilast Tablets Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Apremilast Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Apremilast Tablets Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Apremilast Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Apremilast Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Apremilast Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Apremilast Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Apremilast Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Apremilast Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Apremilast Tablets market include CSPC Ouyi Pharmaceutical, Shanghai Modern Pharmaceutical, Qilu Pharmaceutical, Glenmark Pharmaceuticals and Amgen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Apremilast Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Apremilast Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Apremilast Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Apremilast Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Apremilast Tablets Segment by Company

CSPC Ouyi Pharmaceutical

Shanghai Modern Pharmaceutical

Qilu Pharmaceutical

Glenmark Pharmaceuticals

Amgen

Apremilast Tablets Segment by Type

10mg/Tablet

20mg/Tablet

30mg/Tablet

Apremilast Tablets Segment by Application

Hospital Pharmacy

Retail Pharmacy

Apremilast Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Apremilast Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Apremilast Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Apremilast Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Apremilast Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Apremilast Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Apremilast Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Apremilast Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Apremilast Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Apremilast Tablets industry.

Chapter 3: Detailed analysis of Apremilast Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Apremilast Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Apremilast Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Apremilast Tablets Industry Trends Table 2. Apremilast Tablets Industry Drivers Table 3. Apremilast Tablets Industry Opportunities and Challenges Table 4. Apremilast Tablets Industry Restraints Table 5. Global Apremilast Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Apremilast Tablets Revenue Share by Company (2021-2026) Table 7. Global Apremilast Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Apremilast Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Apremilast Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Apremilast Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Apremilast Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Apremilast Tablets Company, Product Type & Application Table 13. Global Apremilast Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Apremilast Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg/Tablet Table 18. Significant Companies of 20mg/Tablet Table 19. Significant Companies of 30mg/Tablet Table 20. Global Apremilast Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Apremilast Tablets Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Apremilast Tablets Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Apremilast Tablets Sales Volume Share by Type (2021-2026) Table 24. Global Apremilast Tablets Sales Volume Share by Type (2027-2032) Table 25. Global Apremilast Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Apremilast Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Apremilast Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Apremilast Tablets Sales Value Share by Type (2021-2026) Table 29. Global Apremilast Tablets Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Pharmacy Table 31. Significant Companies of Retail Pharmacy Table 32. Global Apremilast Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Apremilast Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Apremilast Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Apremilast Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Apremilast Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Apremilast Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Apremilast Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Apremilast Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Apremilast Tablets Sales Value Share by Application (2021-2026) Table 41. Global Apremilast Tablets Sales Value Share by Application (2027-2032) Table 42. Global Apremilast Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Apremilast Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Apremilast Tablets Sales Market Share by Region (2021-2026) Table 45. Global Apremilast Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Apremilast Tablets Sales Market Share by Region (2027-2032) Table 47. Global Apremilast Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Apremilast Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Apremilast Tablets Sales Value Share by Region (2021-2026) Table 50. Global Apremilast Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Apremilast Tablets Sales Value Share by Region (2027-2032) Table 52. Global Apremilast Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Apremilast Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Apremilast Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Apremilast Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Apremilast Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Apremilast Tablets Sales Market Share by Country (2021-2026) Table 58. Global Apremilast Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Apremilast Tablets Sales Market Share by Country (2027-2032) Table 60. Global Apremilast Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Apremilast Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Apremilast Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Apremilast Tablets Sales Value Market Share by Country (2027-2032) Table 64. CSPC Ouyi Pharmaceutical Company Information Table 65. CSPC Ouyi Pharmaceutical Business Overview Table 66. CSPC Ouyi Pharmaceutical Apremilast Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. CSPC Ouyi Pharmaceutical Apremilast Tablets Product Portfolio Table 68. CSPC Ouyi Pharmaceutical Recent Development Table 69. Shanghai Modern Pharmaceutical Company Information Table 70. Shanghai Modern Pharmaceutical Business Overview Table 71. Shanghai Modern Pharmaceutical Apremilast Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Shanghai Modern Pharmaceutical Apremilast Tablets Product Portfolio Table 73. Shanghai Modern Pharmaceutical Recent Development Table 74. Qilu Pharmaceutical Company Information Table 75. Qilu Pharmaceutical Business Overview Table 76. Qilu Pharmaceutical Apremilast Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Qilu Pharmaceutical Apremilast Tablets Product Portfolio Table 78. Qilu Pharmaceutical Recent Development Table 79. Glenmark Pharmaceuticals Company Information Table 80. Glenmark Pharmaceuticals Business Overview Table 81. Glenmark Pharmaceuticals Apremilast Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Glenmark Pharmaceuticals Apremilast Tablets Product Portfolio Table 83. Glenmark Pharmaceuticals Recent Development Table 84. Amgen Company Information Table 85. Amgen Business Overview Table 86. Amgen Apremilast Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Amgen Apremilast Tablets Product Portfolio Table 88. Amgen Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Apremilast Tablets Distributors List Table 92. Apremilast Tablets Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Apremilast Tablets Product Image Figure 2. Global Apremilast Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Apremilast Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Apremilast Tablets Sales (2021-2032) & (K Units) Figure 5. Global Apremilast Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Apremilast Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg/Tablet Image Figure 10. 20mg/Tablet Image Figure 11. 30mg/Tablet Image Figure 12. Global Apremilast Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Apremilast Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Apremilast Tablets Sales Volume Share by Type (2021-2032) Figure 15. Global Apremilast Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Apremilast Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Apremilast Tablets Sales Value Share by Type (2021-2032) Figure 18. Hospital Pharmacy Image Figure 19. Retail Pharmacy Image Figure 20. Global Apremilast Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Apremilast Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Apremilast Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Apremilast Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Apremilast Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Apremilast Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Apremilast Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Apremilast Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Apremilast Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Apremilast Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Apremilast Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Apremilast Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Apremilast Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Apremilast Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Apremilast Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Apremilast Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Apremilast Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Apremilast Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Apremilast Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Apremilast Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Apremilast Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Apremilast Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Apremilast Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Apremilast Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Apremilast Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/Tablet
  • 20mg/Tablet
  • 30mg/Tablet
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • CSPC Ouyi Pharmaceutical
  • Shanghai Modern Pharmaceutical
  • Qilu Pharmaceutical
  • Glenmark Pharmaceuticals
  • Amgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Apremilast Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Apremilast Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Apremilast Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Apremilast Tablets Market Dynamics
  1. 2.1 Apremilast Tablets Industry Trends
  2. 2.2 Apremilast Tablets Industry Drivers
  3. 2.3 Apremilast Tablets Industry Opportunities and Challenges
  4. 2.4 Apremilast Tablets Industry Restraints
3 Apremilast Tablets Market by Company
  1. 3.1 Global Apremilast Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Apremilast Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Apremilast Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Apremilast Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Apremilast Tablets Company Ranking (2024-2026)
  6. 3.6 Global Apremilast Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Apremilast Tablets Company Product Type and Application
  8. 3.8 Global Apremilast Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Apremilast Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Apremilast Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Apremilast Tablets Market by Type
  1. 4.1 Apremilast Tablets Type Introduction
  2. 4.1.1 10mg/Tablet
  3. 4.1.2 20mg/Tablet
  4. 4.1.3 30mg/Tablet
  5. 4.2 Global Apremilast Tablets Sales Volume by Type
  6. 4.2.1 Global Apremilast Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Apremilast Tablets Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Apremilast Tablets Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Apremilast Tablets Sales Value by Type
  10. 4.3.1 Global Apremilast Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Apremilast Tablets Sales Value by Type (2021-2032)
  12. 4.3.3 Global Apremilast Tablets Sales Value Share by Type (2021-2032)
5 Apremilast Tablets Market by Application
  1. 5.1 Apremilast Tablets Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Apremilast Tablets Sales Volume by Application
  5. 5.2.1 Global Apremilast Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Apremilast Tablets Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Apremilast Tablets Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Apremilast Tablets Sales Value by Application
  9. 5.3.1 Global Apremilast Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Apremilast Tablets Sales Value by Application (2021-2032)
  11. 5.3.3 Global Apremilast Tablets Sales Value Share by Application (2021-2032)
6 Apremilast Tablets Regional Sales and Value Analysis
  1. 6.1 Global Apremilast Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Apremilast Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Apremilast Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Apremilast Tablets Sales by Region (2027-2032)
  5. 6.3 Global Apremilast Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Apremilast Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Apremilast Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Apremilast Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Apremilast Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Apremilast Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Apremilast Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Apremilast Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Apremilast Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Apremilast Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Apremilast Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Apremilast Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Apremilast Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Apremilast Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Apremilast Tablets Sales Value Share by Country, 2025 VS 2032
7 Apremilast Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Apremilast Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Apremilast Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Apremilast Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Apremilast Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Apremilast Tablets Sales by Country (2027-2032)
  6. 7.4 Global Apremilast Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Apremilast Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Apremilast Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Apremilast Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Apremilast Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Apremilast Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Apremilast Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Apremilast Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Apremilast Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Apremilast Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Apremilast Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Apremilast Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Apremilast Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Apremilast Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Apremilast Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Apremilast Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Apremilast Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Apremilast Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Apremilast Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Apremilast Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Apremilast Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Apremilast Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Apremilast Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Apremilast Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Apremilast Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Apremilast Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Apremilast Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Apremilast Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Apremilast Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Apremilast Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Apremilast Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Apremilast Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Apremilast Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CSPC Ouyi Pharmaceutical
  2. 8.1.1 CSPC Ouyi Pharmaceutical Company Information
  3. 8.1.2 CSPC Ouyi Pharmaceutical Business Overview
  4. 8.1.3 CSPC Ouyi Pharmaceutical Apremilast Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CSPC Ouyi Pharmaceutical Apremilast Tablets Product Portfolio
  6. 8.1.5 CSPC Ouyi Pharmaceutical Recent Developments
  7. 8.2 Shanghai Modern Pharmaceutical
  8. 8.2.1 Shanghai Modern Pharmaceutical Company Information
  9. 8.2.2 Shanghai Modern Pharmaceutical Business Overview
  10. 8.2.3 Shanghai Modern Pharmaceutical Apremilast Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Modern Pharmaceutical Apremilast Tablets Product Portfolio
  12. 8.2.5 Shanghai Modern Pharmaceutical Recent Developments
  13. 8.3 Qilu Pharmaceutical
  14. 8.3.1 Qilu Pharmaceutical Company Information
  15. 8.3.2 Qilu Pharmaceutical Business Overview
  16. 8.3.3 Qilu Pharmaceutical Apremilast Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharmaceutical Apremilast Tablets Product Portfolio
  18. 8.3.5 Qilu Pharmaceutical Recent Developments
  19. 8.4 Glenmark Pharmaceuticals
  20. 8.4.1 Glenmark Pharmaceuticals Company Information
  21. 8.4.2 Glenmark Pharmaceuticals Business Overview
  22. 8.4.3 Glenmark Pharmaceuticals Apremilast Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Glenmark Pharmaceuticals Apremilast Tablets Product Portfolio
  24. 8.4.5 Glenmark Pharmaceuticals Recent Developments
  25. 8.5 Amgen
  26. 8.5.1 Amgen Company Information
  27. 8.5.2 Amgen Business Overview
  28. 8.5.3 Amgen Apremilast Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Amgen Apremilast Tablets Product Portfolio
  30. 8.5.5 Amgen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Apremilast Tablets Value Chain Analysis
  2. 9.1.1 Apremilast Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Apremilast Tablets Sales Mode & Process
  6. 9.2 Apremilast Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Apremilast Tablets Distributors
  9. 9.2.3 Apremilast Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst